Literature DB >> 25230214

Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series.

V Gallotta1, F Ghezzi2, E Vizza3, V Chiantera4, M Ceccaroni5, M Franchi6, A Fagotti7, A Ercoli8, F Fanfani9, C Parrino9, S Uccella2, G Corrado3, G Scambia9, G Ferrandina9.   

Abstract

OBJECTIVE: The aim of this study is to analyze the safety, adequacy, perioperative and survival figures in a large series of laparoscopic staging of patients with apparent early stage ovarian malignancies (ESOM). PATIENTS AND METHODS: Retrospective data from seven gynecologic oncology service databases were searched for ESOM patients undergoing immediate laparoscopic staging or delayed laparoscopic staging after an incidental diagnosis of ESOM. Between May 2000 and February 2014, 300 patients were selected: 150 had been submitted to immediate laparoscopic staging (Group 1), while 150 had undergone delayed laparoscopic staging (Group 2) of ESOM. All surgical, pathologic, and oncologic outcome data were analyzed in each group and a comparison between the two was carried out.
RESULTS: Longer operative time, higher blood loss, more frequently spillage/rupture of ovarian capsule and conversion to laparotomy occurred in Group 1. No significant differences of post-operative complications were observed between the two groups. Histological data revealed more frequently serous tumors (0.06), Grade 3 (p=0.0007) and final up-staging (p=0.001) in Group 1. Recurrence and death of disease were documented in 25 (8.3%), and 10 patients (3.3%%), respectively. The 3-year disease free survival (DFS) and overall survival (OS) rates were 85.1%, and 93.6%, respectively in the whole series. There was no difference between Group 1 and Group 2 in terms of DFS (p value=0.39) and OS (p value=0.27).
CONCLUSION: In this very large multi-institutional study, it appears that patients with apparent ESOM can safely undergo laparoscopic surgical management.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early ovarian cancer; Laparoscopy; Ovarian cancer

Mesh:

Year:  2014        PMID: 25230214     DOI: 10.1016/j.ygyno.2014.09.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

Review 1.  New Developments in Minimally Invasive Gynecologic Oncology Surgery.

Authors:  Katherine Ikard Stewart; Amanda N Fader
Journal:  Clin Obstet Gynecol       Date:  2017-06       Impact factor: 2.190

Review 2.  Laparotomy vs. minimally invasive surgery for ovarian cancer recurrence: a systematic review.

Authors:  Stefano Uccella; Massimo P Franchi; Stefano Cianci; Pier Carlo Zorzato; Francesca Bertoli; Salvatore Gueli Alletti; Fabio Ghezzi; Giovanni Scambia
Journal:  Gland Surg       Date:  2020-08

3.  Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors.

Authors:  Koji Matsuo; Hiroko Machida; Tsuyoshi Takiuchi; Brendan H Grubbs; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Gynecol Oncol       Date:  2017-01-26       Impact factor: 5.482

4.  Laparoscopic staging for apparent stage I epithelial ovarian cancer.

Authors:  Alexander Melamed; Nancy L Keating; Joel T Clemmer; Amy J Bregar; Jason D Wright; David M Boruta; John O Schorge; Marcela G Del Carmen; J Alejandro Rauh-Hain
Journal:  Am J Obstet Gynecol       Date:  2016-08-25       Impact factor: 8.661

Review 5.  Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.

Authors:  Anna Fagotti; Federica Perelli; Luigi Pedone; Giovanni Scambia
Journal:  Curr Treat Options Oncol       Date:  2016-01

Review 6.  Is It the Time for Laparoscopic Management of Early-stage Ovarian Malignancies?

Authors:  Tanitra Tantitamit; Chyi-Long Lee
Journal:  Gynecol Minim Invasive Ther       Date:  2018-08-23

Review 7.  Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.

Authors:  Sari Sjövall; Merja Kokki; Hannu Kokki
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

8.  LESS with Suture Suspension for Early-Stage Adnexa Cancer Staging.

Authors:  Chen Lin; Zheng Ying; Qi Xiao Rong; Chen Sijing; Min Ling; Jia Xi Biao
Journal:  JSLS       Date:  2019 Jul-Sep       Impact factor: 2.172

9.  Prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

Authors:  Jenn Jhy Tseng; Chun Che Huang; Hsiu Yin Chiang; Yi Huei Chen; Ching Heng Lin
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

10.  Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: a meta-analysis of clinical studies.

Authors:  Ying Zhang; Shuying Fan; Yang Xiang; Hua Duan; Li Sun
Journal:  BMC Cancer       Date:  2015-08-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.